Prof Charlie Hodgman
Professor of Bioinformatics and Systems Biology
Following a Bachelors degree in Biochemistry in 1976, Charlie first worked in the ICI Corporate laboratory in their gene cloning group, and dates his first informatics project to 1980. This same year, he moved to Cambridge to carry out a PhD in clinical virology and stayed on to carry out postdoctoral research in plant virology, microbial insecticides, biotechnology and the effects of trisomy 21. During this period he acquired an international reputation for his application of informatics and mathematics to practical biological research problems.
It is no surprise therefore that he was recruited to GlaxoWellcome in 1995, where he applied his expertise across the Drug Discovery pipeline and even out to manufacturing and intellectual property management. Shortly after joining the company, he began promoting what is now known as Integrative Systems Biology and eventually headed the in-house team working on the development of a virtual E.coli (to predict drug-precursor product yields in fermenters).
He was increasingly called onto Research Council funding panels and governmental strategy groups. He moved to the University of Nottingham in 2004 to propagate his multidisciplinary research in an academic setting.